Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Capecitabine and Oxaliplatin or Irinotecan in Metastatic Colorectal Cancer
NCT00314353Phase 2Terminated
- Sponsor
- NSABP Foundation
- Start
- Mar 2006
- Primary completion
- May 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by NSABP Foundation. Started Mar 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00314353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314353.